Interleukin-38 is a negative regulator of trained immunity—A retrospective multi-omics study [PDF]
Summary: Trained immunity is a long-lasting innate immune cell phenotype with benefits in infection control and recognized anti-cancer effects. Conversely, inappropriately induced trained immunity contributes to pathological inflammation, warranting the ...
Lisa U. Teufel +12 more
doaj +2 more sources
Evidence showed that chronic inflammatory and immunopathological responses play a pivotal role in the development of osteoarthritis (OA). Interleukin-38 (IL-38) as a novel anti-inflammatory cytokine with influential modulatory properties on both innate ...
Mitra Abassifard +3 more
doaj +2 more sources
The Effect of Interleukin 38 on Angiogenesis in a Model of Oxygen-induced Retinopathy [PDF]
Interleukin 38 (IL-38) is a novel identified cytokine of IL-1 family in which some members are important in inflammation and angiogenesis. However, the role of IL-38 in regulating angiogenesis is unknown.
Jing Zhang +9 more
doaj +2 more sources
Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses. [PDF]
Different modes of cell death regulate immunity. Whereas necrotic (necroptotic, pyroptotic) cell death triggers inflammation, apoptosis contributes to its resolution. Interleukin-1 (IL-1) family cytokines are key players in this interaction. A number of IL-1 family cytokines are produced by necrotic cells to induce sterile inflammation.
Javier Mora +10 more
semanticscholar +3 more sources
Recombinant IL-38 Alleviates Temporomandibular Joint Synovial Inflammation via IL-1R1-NF-κB-IL1β Pathway [PDF]
Introduction and aims: Interleukin (IL)-38 has been identified as an anti-inflammatory cytokine; however, its specific role in temporomandibular joint (TMJ) synovial inflammation and the identity of its functional receptors remain elusive.
Ping Luo +3 more
doaj +2 more sources
IL-38 as a Novel Biomarker in Multiple Myeloma Patients: A Prospective Clinical Evaluation [PDF]
Hailan Shen, Ping Zhao, Ju Cao Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaCorrespondence: Ju Cao, Department of Laboratory Medicine, The First Affiliated Hospital
Shen H, Zhao P, Cao J
doaj +2 more sources
Interleukin-38 promotes tumor growth through regulation of CD8+ tumor-infiltrating lymphocytes in lung cancer tumor microenvironment. [PDF]
Kinoshita F +15 more
europepmc +2 more sources
Retraction ‘Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression’ [PDF]
Feng Wang +3 more
doaj +2 more sources
Objective To investigate the roles of cytokines, IL-36γ and IL-38, in the inflammatory response in psoriasis vulgaris. Methods Both serum and peripheral blood mononuclear cells (PBMC) were collected from 29 patients with psoriasis vulgaris (PV) and 19 ...
Jiao ZHANG +4 more
doaj +1 more source
Anti-inflammatory Mechanisms of IL-38 in Chinese Patients with Allergic Rhinitis [PDF]
Background: T-helper 17 (Th17) cell response is engaged in the onset of allergic rhinitis (AR). Moreover, interleukin (IL)-38 is thought to be involved in inhibiting cytokine secretion in the Th17 pathway.Objective: To evaluate the regulatory function of
Xiaoqiang Wang +3 more
doaj +1 more source

